Science Explorer Back to mapMap
Discussion

Erlend Bremertun Smeland

Erlend Bremertun Smeland publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as Lymphoma Diagnosis and Treatment, CAR-T cell therapy research and T-cell and B-cell Immunology.

OpenAlex
World rank
#428,644
of 7,710,434 ranked researchers
Rank in Norway
#2,608
of 33,005
Works
269
Citations
25k
Citations per work
93.8
h-index
62
i10-index 146Top 1.8% in Molecular Biology

What does Erlend Bremertun Smeland research?

Erlend Bremertun Smeland's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (17%).

Life Sciences36%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine10137.5%
    1. Biochemistry, Genetics and Molecular Biology5219.4%
    2. Immunology and Microbiology4516.6%
  1. Everything else7126.5%
  1. 1Molecular Biology19% of their works
  2. 2Immunology17% of their works
  3. 3Oncology14% of their works
  4. 4Pathology and Forensic Medicine14% of their works
  5. 5Hematology5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Erlend Bremertun Smeland's research?

The keywords of their largest research topics: Lymphoma, Rituximab, Classification, Molecular Profiling, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor and Foxp3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Lymphoma1202 topics
  2. Rituximab1022 topics
  3. Classification841 topic
  4. Molecular Profiling841 topic
  5. Cancer Immunotherapy522 topics
  6. CAR T Cells361 topic
  7. Chimeric Antigen Receptor361 topic
  8. Foxp3341 topic
  9. TGF-ß341 topic
  10. NK Cell Recognition291 topic
  11. Natural Killer Cells291 topic
  12. Fc Receptors281 topic
  13. Therapeutic Antibodies281 topic
  14. Chronic Lymphocytic Leukemia181 topic
  15. Genomic Aberrations181 topic
  16. Dendritic Cells161 topic
  17. Epstein-Barr Virus161 topic
  18. Immunity161 topic
  19. Kaposi's Sarcoma161 topic

Where does Erlend Bremertun Smeland work?

Erlend Bremertun Smeland's main affiliation in the publication record is Norwegian Cancer Society, Norway.

How many publications and citations does Erlend Bremertun Smeland have?

OpenAlex counts 269 works and 25,232 citations for Erlend Bremertun Smeland, an h-index of 62, ranking #428,644 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Erlend Bremertun Smeland. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.